Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AHD International is a specialized supplier and distributor of functional ingredients for the nutraceutical, food, and beverage industries. The company is well-known for its portfolio of science-based ingredients, including LuraLean, a highly purified glucomannan used for weight management and cholesterol reduction. AHD provides value-added services such as custom formulation, sourcing, and technical support to manufacturers of dietary supplements. Following its acquisition by RFI Ingredients in 2013, AHD's operations were integrated into RFI's broader network of sustainable ingredient solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AHD International.